134 related articles for article (PubMed ID: 33098022)
1. Arterial Embolization Using Microspheres for Hypervascular Liver Metastases Refractory to Standard Treatments: A Multicenter Prospective Clinical Trial.
Shimohira M; Sato Y; Yasumoto T; Kodama Y; Masada T; Inaba Y; Yamakado K
Cardiovasc Intervent Radiol; 2021 Mar; 44(3):392-400. PubMed ID: 33098022
[TBL] [Abstract][Full Text] [Related]
2. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R
Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
4. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
5. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
[TBL] [Abstract][Full Text] [Related]
6. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
Chen JX; Wileyto EP; Soulen MC
Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan.
Hiraki T; Koizumi J; Arai Y; Sakurai Y; Kumada H; Nambu Y; Hori S
Jpn J Radiol; 2015 Aug; 33(8):479-86. PubMed ID: 26111877
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study.
Yamakado K; Inaba Y; Sato Y; Yasumoto T; Hayashi S; Yamanaka T; Nobata K; Takaki H; Nakatsuka A
Cardiovasc Intervent Radiol; 2017 Apr; 40(4):560-567. PubMed ID: 27999917
[TBL] [Abstract][Full Text] [Related]
10. Transarterial embolization of hypervascular tumors using trisacryl gelatin microspheres (Embosphere): a prospective multicenter clinical trial in Japan.
Osuga K; Nakajima Y; Sone M; Arai Y; Nambu Y; Hori S
Jpn J Radiol; 2016 May; 34(5):366-75. PubMed ID: 26965917
[TBL] [Abstract][Full Text] [Related]
11. Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
Mauri G; Varano GM; Della Vigna P; Bonomo G; Monfardini L; Zampino MG; Ravenda PS; Orsi F
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1708-1715. PubMed ID: 29951693
[TBL] [Abstract][Full Text] [Related]
12. Towards new response criteria in neuroendocrine tumors: which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?
Ceelen F; Theisen D; de Albéniz XG; Auernhammer CJ; Haug AR; D'Anastasi M; Paprottka PM; Rist C; Reiser MF; Sommer WH
J Magn Reson Imaging; 2015 Feb; 41(2):361-8. PubMed ID: 24446275
[TBL] [Abstract][Full Text] [Related]
13.
Kurilova I; Beets-Tan RGH; Ulaner GA; Boas FE; Petre EN; Yarmohammadi H; Ziv E; Deipolyi AR; Brody LA; Gonen M; Sofocleous CT
Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1419-1427. PubMed ID: 29766239
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
15. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
Fidelman N; Kerlan RK; Hawkins RA; Taylor AG; Kohi MP; Kolli KP; Bergsland EK; Kelley RK; Ko AH; Korn WM; McWhirter RM; Luan J; Venook AP
J Gastrointest Cancer; 2014 Jun; 45(2):168-80. PubMed ID: 24448917
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Safety of CT-Guided High-Dose-Rate Brachytherapy Combined with Transarterial Chemoembolization Using Irinotecan-Loaded Microspheres for the Treatment of Large, Unresectable Colorectal Liver Metastases.
Collettini F; Jonczyk M; Meddeb A; Wieners G; Geisel D; Schnapauff D; Gebauer B
J Vasc Interv Radiol; 2020 Feb; 31(2):315-322. PubMed ID: 31537409
[TBL] [Abstract][Full Text] [Related]
19. [Chemoembolization for unresectable colorectal liver metastases with drug-eluting microspheres].
Skupchenko AV; Lysenko AV; Korolev DG; Skobel'tsov DA; Rassudishkin AS
Vestn Rentgenol Radiol; 2014; (6):33-8. PubMed ID: 25975131
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?
Sangha BS; Nimeiri H; Hickey R; Salem R; Lewandowski RJ
Curr Treat Options Oncol; 2016 Jun; 17(6):26. PubMed ID: 27098532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
